Advertisement
Monday, Jan 24, 2022
Outlook.com
Outlook.com

More Information Required From Bharat Biotech For Emergency Use Listing Of Covaxin: WHO

According to sources, Bharat Biotech informed the Centre that it has already submitted 90 per cent of documents required for Emergency Use Listing to WHO and that it will submit the rest by June

More Information Required From Bharat Biotech For Emergency Use Listing Of Covaxin: WHO
Covaxin has already received regulatory approval from 11 countries | File Photo
More Information Required From Bharat Biotech For Emergency Use Listing Of Covaxin: WHO
outlookindia.com
2021-05-25T08:07:53+05:30

While the World Health Organisation (WHO) has said that it requires “more information from Bharat Biotech to grant emergency use listing (EUL) for Covaxin, the Hyderabad-based company has claimed that it has already submitted about 90 per cent of documents required for EUL.

Further, the company informed the Centre that it would submit rest of the required documents by June and Bharat Biotech officials exuded confidence of receiving EUL for Covaxin, sources told PTI.

According to the WHO, it will most likely conduct a pre-submission meeting with Bharat Biotech between May-June.

The international body states that submissions to it for prequalification or listing under the emergency use procedure are confidential.

If a product submitted for assessment is found to meet the criteria for listing, WHO will publish the results widely. Duration of the emergency use listing process depends on the quality of the data submitted by the vaccine manufacturer and on those data meeting WHO criteria, according to the agency.

Noting that Covaxin has already received regulatory approval from 11 countries, sources told PTI there was also interest from other 11 companies in seven nations for technology transfer and production of Covaxin.

The company is in the final stages of negotiations with the Food and Drug Administration of the US for conducting small-scale phase-III clinical trials of Covaxin in the United States, sources said.

Sources said the meeting with BBIL on the EUL was attended by the company's managing director V Krishna Mohan and his colleagues besides senior officers of the Ministry of Health, Department of Biotechnology and Ministry of External Affairs.

Foreign Secretary Harsh Vardhan Shringla was among those who attended the meeting.

(With PTI inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

In happy times and sad, Habba Khatun’s sensuous songs make both young and old emotional. With the never-ending conflict bringing tragedies to every doorstep, Habba’s lyrics of separation amplify their mourning.

How Indian Laws Govern People’s Right To Love And Live

How Indian Laws Govern People’s Right To Love And Live

In India, only those relationships between a man and a woman are considered to be legitimate when there is a marriage between the two.

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Virat Kohli, 33, had recently stepped down as India's T20I captain and was subsequently removed as the ODI captain.

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

A Mahila Congress leader, who is the face of the ‘Ladki Hoon, Lad Sakti Hoon’ campaign, however, has accused the party of anti-women bias after she was denied a ticket.

Advertisement